BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 24141201)

  • 1. Synthetic cannabinoid quinones: preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity.
    Morales P; Vara D; Goméz-Cañas M; Zúñiga MC; Olea-Azar C; Goya P; Fernández-Ruiz J; Díaz-Laviada I; Jagerovic N
    Eur J Med Chem; 2013; 70():111-9. PubMed ID: 24141201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antitumor activity of quinonoid derivatives of cannabinoids.
    Kogan NM; Rabinowitz R; Levi P; Gibson D; Sandor P; Schlesinger M; Mechoulam R
    J Med Chem; 2004 Jul; 47(15):3800-6. PubMed ID: 15239658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells.
    Sanderson JT; Clabault H; Patton C; Lassalle-Claux G; Jean-François J; Paré AF; Hébert MJ; Surette ME; Touaibia M
    Bioorg Med Chem; 2013 Nov; 21(22):7182-93. PubMed ID: 24080105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boc-lysinated-betulonic acid: a potent, anti-prostate cancer agent.
    Saxena BB; Zhu L; Hao M; Kisilis E; Katdare M; Oktem O; Bomshteyn A; Rathnam P
    Bioorg Med Chem; 2006 Sep; 14(18):6349-58. PubMed ID: 16777417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of novel quinazoline nitrogen mustard derivatives as potential therapeutic agents for cancer.
    Li S; Wang X; He Y; Zhao M; Chen Y; Xu J; Feng M; Chang J; Ning H; Qi C
    Eur J Med Chem; 2013 Sep; 67():293-301. PubMed ID: 23871909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on quinones. Part 42: Synthesis of furylquinone and hydroquinones with antiproliferative activity against human tumor cell lines.
    Benites J; Valderrama JA; Rivera F; Rojo L; Campos N; Pedro M; José Nascimento MS
    Bioorg Med Chem; 2008 Jan; 16(2):862-8. PubMed ID: 17964791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake and antitumoral effects of iodine and 6-iodolactone in differentiated and undifferentiated human prostate cancer cell lines.
    Aranda N; Sosa S; Delgado G; Aceves C; Anguiano B
    Prostate; 2013 Jan; 73(1):31-41. PubMed ID: 22576883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
    Suy S; Mitchell JB; Samuni A; Mueller S; Kasid U
    Cancer; 2005 Mar; 103(6):1302-13. PubMed ID: 15685617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of quinones as novel PIM1 kinase inhibitors.
    Schroeder RL; Goyal N; Bratton M; Townley I; Pham NA; Tram P; Stone T; Geathers J; Nguyen K; Sridhar J
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3187-3191. PubMed ID: 27173800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BND-12, a novel nonhaematotoxic naphthalimide derivative, inhibits tumour growth and metastasis of hepatocellular carcinoma.
    Xie SQ; Li Q; Zhang YH; Li Z; Zhao J; Wang CJ
    J Pharm Pharmacol; 2012 Oct; 64(10):1483-90. PubMed ID: 22943179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of phenyl substituted polyoxygenated xanthone derivatives as anti-hepatoma agents.
    Dai M; Yuan X; Kang J; Zhu ZJ; Yue RC; Yuan H; Chen BY; Zhang WD; Liu RH; Sun QY
    Eur J Med Chem; 2013 Nov; 69():159-66. PubMed ID: 24013415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel epoxypropoxy flavonoid derivative and topoisomerase II inhibitor, MHY336, induces apoptosis in prostate cancer cells.
    Patra N; De U; Kang JA; Kim JM; Ahn MY; Lee J; Jung JH; Chung HY; Moon HR; Kim HS
    Eur J Pharmacol; 2011 May; 658(2-3):98-107. PubMed ID: 21376033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
    Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
    Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R
    Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic strigolactone analogues reveal anti-cancer activities on hepatocellular carcinoma cells.
    Hasan MN; Choudhry H; Razvi SS; Moselhy SS; Kumosani TA; Zamzami MA; Omran Z; Halwani MA; Al-Babili S; Abualnaja KO; Al-Malki AL; Alhosin M; Asami T
    Bioorg Med Chem Lett; 2018 Apr; 28(6):1077-1083. PubMed ID: 29456109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New platinum(II) complexes conjugated at position 7α of 17β-acetyl-testosterone as new combi-molecules against prostate cancer: design, synthesis, structure-activity relationships and biological evaluation.
    Fortin S; Brasseur K; Morin N; Asselin É; Bérubé G
    Eur J Med Chem; 2013 Oct; 68():433-43. PubMed ID: 23994871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A monocarbonyl analogue of curcumin, 1,5-bis(3-hydroxyphenyl)-1,4-pentadiene-3-one (Ca 37), exhibits potent growth suppressive activity and enhances the inhibitory effect of curcumin on human prostate cancer cells.
    Luo C; Li Y; Zhou B; Yang L; Li H; Feng Z; Li Y; Long J; Liu J
    Apoptosis; 2014 Mar; 19(3):542-53. PubMed ID: 24297639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biological evaluation and molecular docking study of 1-amino-2-aroylnaphthalenes against prostate cancer.
    Rai R; Dutta RK; Singh S; Yadav DK; Kumari S; Singh H; Gupta RD; Pratap R
    Bioorg Med Chem Lett; 2018 May; 28(9):1574-1580. PubMed ID: 29606573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
    Kubota T; Koshizuka K; Williamson EA; Asou H; Said JW; Holden S; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3344-52. PubMed ID: 9699665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.